ArticleOncogene2007

Molecular profiling of malignant peritoneal mesothelioma identifies the ubiquitin-proteasome pathway as a therapeutic target in poor prognosis tumors.

A C Borczuk et al.PubMed ↗Publisher ↗

No numbers read from the abstract.